JP2017501990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017501990A5 JP2017501990A5 JP2016536146A JP2016536146A JP2017501990A5 JP 2017501990 A5 JP2017501990 A5 JP 2017501990A5 JP 2016536146 A JP2016536146 A JP 2016536146A JP 2016536146 A JP2016536146 A JP 2016536146A JP 2017501990 A5 JP2017501990 A5 JP 2017501990A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- building block
- chain
- lipopeptide building
- long
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 31
- 108010028921 Lipopeptides Proteins 0.000 claims description 21
- 150000002632 lipids Chemical group 0.000 claims description 18
- 239000000427 antigen Substances 0.000 claims description 15
- 102000036639 antigens Human genes 0.000 claims description 15
- 108091007433 antigens Proteins 0.000 claims description 15
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 14
- 150000001413 amino acids Chemical class 0.000 claims description 12
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 5
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 5
- 239000000539 dimer Substances 0.000 claims description 3
- 239000013638 trimer Substances 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims 8
- 229940024606 amino acid Drugs 0.000 claims 8
- 101710088675 Proline-rich peptide Proteins 0.000 claims 7
- 235000008206 alpha-amino acids Nutrition 0.000 claims 6
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- 239000004472 Lysine Substances 0.000 claims 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001371 alpha-amino acids Chemical class 0.000 claims 2
- 125000000129 anionic group Chemical group 0.000 claims 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000002091 cationic group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- 230000002209 hydrophobic effect Effects 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 241000295644 Staphylococcaceae Species 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 159000000032 aromatic acids Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 235000004554 glutamine Nutrition 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- -1 one peptide Chemical class 0.000 claims 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 235000004400 serine Nutrition 0.000 claims 1
- 235000008521 threonine Nutrition 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13195402 | 2013-12-03 | ||
| EP13195402.6 | 2013-12-03 | ||
| PCT/EP2014/076313 WO2015082501A1 (en) | 2013-12-03 | 2014-12-02 | Proline-rich peptides protective against s. pneumoniae |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019217485A Division JP2020073487A (ja) | 2013-12-03 | 2019-11-29 | 肺炎連鎖球菌（Ｓ．ｐｎｅｕｍｏｎｉａｅ）に対して防御的なプロリンリッチペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017501990A JP2017501990A (ja) | 2017-01-19 |
| JP2017501990A5 true JP2017501990A5 (enExample) | 2019-03-28 |
Family
ID=49765797
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016536146A Pending JP2017501990A (ja) | 2013-12-03 | 2014-12-02 | 肺炎連鎖球菌（Ｓ．ｐｎｅｕｍｏｎｉａｅ）に対して防御的なプロリンリッチペプチド |
| JP2019217485A Pending JP2020073487A (ja) | 2013-12-03 | 2019-11-29 | 肺炎連鎖球菌（Ｓ．ｐｎｅｕｍｏｎｉａｅ）に対して防御的なプロリンリッチペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019217485A Pending JP2020073487A (ja) | 2013-12-03 | 2019-11-29 | 肺炎連鎖球菌（Ｓ．ｐｎｅｕｍｏｎｉａｅ）に対して防御的なプロリンリッチペプチド |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9943583B2 (enExample) |
| EP (1) | EP3077410B1 (enExample) |
| JP (2) | JP2017501990A (enExample) |
| KR (1) | KR20160088323A (enExample) |
| CN (1) | CN105793276A (enExample) |
| AU (1) | AU2014359292B2 (enExample) |
| BR (1) | BR112016012306A2 (enExample) |
| CA (1) | CA2931570A1 (enExample) |
| HK (1) | HK1225739A1 (enExample) |
| RU (1) | RU2737638C2 (enExample) |
| WO (1) | WO2015082501A1 (enExample) |
| ZA (1) | ZA201603962B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10287328B2 (en) | 2016-03-08 | 2019-05-14 | KeMyth Biotech Co., Ltd. | Treatment of diabetes, toll-like receptor 4 modulators and methods for using the same |
| US11806392B2 (en) * | 2016-12-03 | 2023-11-07 | The Uab Research Foundation | Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A |
| CN110891592B (zh) | 2017-06-14 | 2024-08-13 | 维罗米蒂克斯股份公司 | 用于保护免受呼吸道合胞病毒的环状肽 |
| CN108559784B (zh) * | 2018-07-06 | 2021-08-20 | 陕西省动物研究所 | 一种同时检测三种病原菌的三重pcr检测用引物、探针、试剂盒及检测方法 |
| EP3897708A1 (en) * | 2018-12-20 | 2021-10-27 | Virometix AG | Lipopeptide building blocks and synthetic virus-like particles |
| WO2020192701A1 (en) * | 2019-03-25 | 2020-10-01 | Immunwork Inc. | Composite polypeptide having a metal binding motif and molecular construct comprising the same |
| CN113631186B (zh) * | 2019-03-29 | 2024-10-29 | 国立大学法人东京大学 | 肺炎球菌表面蛋白 |
| WO2021260176A1 (en) | 2020-06-25 | 2021-12-30 | Virometix Ag | Synthetic epitopes of betacoronaviruses |
| US20230355737A1 (en) | 2020-09-28 | 2023-11-09 | Dbv Technologies | Particle comprising an rsv-f protein for use in rsv vaccination |
| CN121693342A (zh) | 2023-07-12 | 2026-03-17 | 维罗迈科斯股份公司 | 肺炎球菌抗原的组合物 |
| WO2025242657A1 (en) | 2024-05-21 | 2025-11-27 | Shape Biopharmaceuticals Ag | Lipopeptide building blocks and aggregates |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663160A (en) * | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
| GB8704647D0 (en) | 1987-02-27 | 1987-04-01 | Guy S & St Thomas S Hospitals | Vaccine |
| US6592876B1 (en) * | 1993-04-20 | 2003-07-15 | Uab Research Foundation | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| US5391712A (en) | 1991-08-30 | 1995-02-21 | Beckman Instruments, Inc. | Non-hemolytic streptolysin O variants |
| GB9202219D0 (en) * | 1992-02-03 | 1992-03-18 | Connaught Lab | A synthetic heamophilus influenzae conjugate vaccine |
| US6251405B1 (en) * | 1995-06-07 | 2001-06-26 | Connaught Laboratories, Inc. | Immunological combination compositions and methods |
| WO1997037026A1 (en) | 1996-04-02 | 1997-10-09 | Smithkline Beecham Corporation | Novel compounds |
| WO1997043304A1 (en) | 1996-05-14 | 1997-11-20 | Smithkline Beecham Corporation | Novel compounds |
| US6096863A (en) | 1996-08-23 | 2000-08-01 | Regents Of The University Of Minnesota | Self-assembling amphiphiles for construction of peptide secondary structures |
| CA2271720A1 (en) | 1996-10-31 | 1998-05-07 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| US6800744B1 (en) | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| CN1285753A (zh) | 1997-12-02 | 2001-02-28 | 鲍德杰克特疫苗公司 | 透皮给药微粒疫苗组合物 |
| IT1320157B1 (it) | 2000-01-27 | 2003-11-18 | Combistone Italia S P A | Piano e/o rivestimento per arredamento e procedimento per la suaproduzione. |
| ATE439372T1 (de) | 2000-10-27 | 2009-08-15 | Novartis Vaccines & Diagnostic | Nukleinsäuren und proteine von gruppen a und b- streptokokken |
| GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| JP2004533236A (ja) | 2001-04-13 | 2004-11-04 | ワイエス | 化膿性連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｙｏｇｅｎｅｓ）の表面タンパク質 |
| GB0210128D0 (en) | 2002-05-02 | 2002-06-12 | Chiron Spa | Nucleic acids and proteins from streptococcus groups A & B |
| WO2004041157A2 (en) | 2002-09-13 | 2004-05-21 | Chiron Corporation | Group b streptococcus vaccine |
| CA2526106A1 (en) | 2003-06-26 | 2005-01-13 | Chiron Corporation | Immunogenic compositions for chlamydia trachomatis |
| US8808704B2 (en) | 2006-02-02 | 2014-08-19 | The Uab Research Foundation | Non-coiled protective regions of pneumococcal surface proteins PspA and PspC |
| PT2121732E (pt) | 2006-12-09 | 2012-10-02 | Univ Zuerich Prorektorat Forschung | Feixes helicoidais de lipopéptidos de hélices enroladas e partículas sintéticas semelhantes a vírus |
| WO2012100234A1 (en) | 2011-01-20 | 2012-07-26 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
-
2014
- 2014-12-02 AU AU2014359292A patent/AU2014359292B2/en not_active Ceased
- 2014-12-02 JP JP2016536146A patent/JP2017501990A/ja active Pending
- 2014-12-02 BR BR112016012306A patent/BR112016012306A2/pt not_active IP Right Cessation
- 2014-12-02 HK HK16113900.4A patent/HK1225739A1/zh unknown
- 2014-12-02 CN CN201480066380.7A patent/CN105793276A/zh active Pending
- 2014-12-02 RU RU2016126433A patent/RU2737638C2/ru active
- 2014-12-02 US US15/101,214 patent/US9943583B2/en active Active
- 2014-12-02 EP EP14805634.4A patent/EP3077410B1/en active Active
- 2014-12-02 CA CA2931570A patent/CA2931570A1/en not_active Abandoned
- 2014-12-02 KR KR1020167014493A patent/KR20160088323A/ko not_active Ceased
- 2014-12-02 WO PCT/EP2014/076313 patent/WO2015082501A1/en not_active Ceased
-
2016
- 2016-06-10 ZA ZA2016/03962A patent/ZA201603962B/en unknown
-
2018
- 2018-02-28 US US15/908,306 patent/US20180256698A1/en not_active Abandoned
-
2019
- 2019-11-29 JP JP2019217485A patent/JP2020073487A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512308A5 (ja) | コイルドコイル構造を有するリポペプチドビルディングブロック、リポペプチドヘリックスバンドル、合成ウイルス様粒子、および医薬製剤 | |
| CY1123526T1 (el) | Καινοτομος ανοσοθεραπεια εναντι διαφορων ογκων συμπεριλαμβανομενων ογκων των νευρωνων και του εγκεφαλου | |
| CY1123447T1 (el) | Καινοτομος ανοσοθεραπεια εναντι διαφορων ογκων συμπεριλαμβανομενου του γαστρεντερικου και του γαστρικου καρκινου | |
| RU2015146614A (ru) | Конъюгированная вакцина на основе пептида антигена wt1 | |
| JP2016196472A5 (enExample) | ||
| BR112016012306A2 (pt) | peptídeos ricos em prolina para proteção contra s. pneumoniae | |
| JP2015513533A5 (enExample) | ||
| JP2014509838A5 (enExample) | ||
| JP2010518082A5 (enExample) | ||
| JP2015501656A5 (enExample) | ||
| JP2015528443A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| MX363443B (es) | Proteinas de tipo espiral enrollada modificadas que tienen propiedades mejoradas. | |
| IL276170B2 (en) | Lipid-modified relaxin B peptide chains and their medical use | |
| RU2017135038A (ru) | Пептид, полученный из gpc3, фармацевтическая композиция для лечения или предотвращения рака с его использованием, индуктор иммунитета и способ получения антиген-презентирующих клеток | |
| JP2012529293A5 (enExample) | ||
| JP2016138090A5 (enExample) | ||
| JP2016520534A5 (enExample) | ||
| JP2015513314A5 (enExample) | ||
| JP2018536645A5 (enExample) | ||
| EP3208334A3 (en) | Cdc45l peptides and vaccines including the same | |
| PH12013501105A1 (en) | Tomm34 peptides and vaccines including the same | |
| JP6975716B2 (ja) | 樹状細胞標的化ペプチド、当該ペプチドを利用したペプチド融合体、及び当該ペプチド融合体を利用したワクチン | |
| CA3252229A1 (en) | TUMOR ANTIGENS, COMPOUNDS INCLUDING THE TUMOR ANTIGENS KRAS, TPX2 OR AURKA AND THEIR USES |